European Archives - Page 69 of 1138 - European Medical Journal

Jonathan Sackier, hema now highlights

Hema Now: Episode 13: Hema Now Highlights

Take look back at Jonathan Sackier’s highlights from the Hema Now podcast so far, exploring CAR-T therapies, bispecific antibodies and more.

Lung Cancer Screening Adherence Declines, Reducing Detection Rates

A multicentre cohort study found that adherence to annual lung cancer screening declines over time, with lower adherence linked to reduced lung cancer detection rates.

Comorbidities and COVID-19 Mortality in Cancer Patients

A recent study has revealed a significant disparity in COVID-19 mortality rates between Non-Hispanic Black and Non-Hispanic White cancer patients….

Long-Acting Injectable HIV Therapy Shows Early Promise in Human Trials

A first-in-human study evaluating a novel long-acting injectable antiretroviral therapy has provided promising early results on its safety and pharmacokinetics.

New Endoscopic Technique Successfully Removes Gastric Fundal Tumours

A novel minimally invasive endoscopic technique has proven safe and effective in removing gastric fundal subepithelial lesions, including low-risk GISTs, according to a recent study.

Acne Scar Treatment: 70% or 100% Trichloroacetic Acid?

The findings of this study suggest that both 70% and 100% TCA achieve similar overall results.

ECR 2025 Interview: Patrizia Cornacchione

While it does not have a simple answer, I must acknowledge the remarkable work of my predecessors, who have dedicated great effort…

T-TEER Safe and Effective for Tricuspid Regurgitation in Patients with Endocardial Leads

Discover how TriClip improves heart function in pacemaker users. Find out why experts are optimistic.

Pharma’s trillion-dollar opportunity: Investing in women’s health

Women’s health remains chronically underfunded, yet closing the gap could unlock huge value for women and the global economy.

Optimising Radiotherapy Treatment for Localised Prostate Cancer

Discover how isodose MHFRT offers comparable cancer control to CFRT with fewer gastrointestinal side effects, improving patient outcomes.